OraSure to Present at J.P Morgan Healthcare Conference
J.P. Morgan turned cautious on the eVTOL sector as it attempted to balance the near-term relativeshare price outperformance ...
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced ...
J.P. Morgan Chase, with about 300,000 employees worldwide, is expected to announce the end of hybrid and remote work in the ...
J.P. Morgan analyst Doug Anmuth said he sees room for Alphabet, Google’s parent, to gain ground on a variety of fronts, ...
J.P. Morgan Asset Management’s Michael Cembalest calls them “Alchemists” — the Trump White House nominees who are looking to ...
In a report released on January 7, Jeremy Tonet from J.P. Morgan maintained a Buy rating on Constellation Energy Corporation (CEG – Research ...
The banking giant has filed two lawsuits, one in Greece for €916m and one in the U.K., against WeRealize, in an ongoing legal dispute over their co-owned business, Viva Wallet.
M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next ...
J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced today announced its ...
The Los Angeles wildfires are now expected to exceed $20B, J.P. Morgan analyst Jimmy Bhullar estimated Thursday, doubling his ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback